Literature DB >> 16379633

Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992-2000).

Christopher J Dillon1, G Neal Mauldin, Keith E Baer.   

Abstract

OBJECTIVE: To identify factors associated with outcome of cats with nonvisceral soft tissue sarcomas treated with surgery alone.
DESIGN: Retrospective study. ANIMALS: 42 cats. PROCEDURE: Medical records were reviewed for clinically relevant data, and histologic samples were examined. Follow-up information was obtained by means of physical examination or through telephone conversations with referring veterinarians and owners. The Kaplan-Meier method was used to construct survival curves.
RESULTS: Median survival time was 608 days (range, 85 to 2,291 days), although 24 cats were still alive at the time of the study. Tumor size (ie, diameter) and histologic type were significantly associated with survival time. Median survival time was significantly longer in cats with tumors that were < 2 cm in diameter, compared with cats in which tumors were > 2 cm. Median survival times for cats with a fibrosarcoma or nerve sheath tumor were significantly longer than median time for cats with a malignant fibrous histiocytoma. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that tumor size and type are significantly associated with survival time in cats with nonvisceral soft tissue tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16379633     DOI: 10.2460/javma.2005.227.1955

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

Review 1.  Vaccine-associated feline sarcoma: current perspectives.

Authors:  Corey F Saba
Journal:  Vet Med (Auckl)       Date:  2017-01-12

2.  Colonic malignant peripheral nerve sheath tumour in a cat.

Authors:  Lara Boland; Laura Setyo; Cheryl Sangster; Laurencie Brunel; Timothy Foo; Peter Bennett
Journal:  JFMS Open Rep       Date:  2019-05-28

3.  Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.

Authors:  Filippo Torrigiani; Giorgio Romanelli; Paola Roccabianca; Elisabetta Treggiari
Journal:  JFMS Open Rep       Date:  2019-07-01

4.  Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.

Authors:  Verena Hampel; Bianca Schwarz; Christine Kempf; Roberto Köstlin; Ulrike Schillinger; Helmut Küchenhoff; Nora Fenske; Thomas Brill; Johannes Hirschberger
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.